Under the engagement, Thrivable will tap into its 140,000+ triple-verified patient panel to conduct in-depth engagement with 20 individuals living with diabetes and deliver a survey with an additional 300 insulin-using patients.
San Diego, CA, July 14, 2026 - Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today announced positive findings from a new comprehensive diabetes patient research initiative further supporting its commercialization strategy. The Company will share these findings and showcase its Pivot™ tubeless insulin patch pump at the upcoming Association of Diabetes Care & Education Specialists (ADCES) Annual Conference in Columbus, Ohio, August 7-10, 2026.
Read the full press release on BioSpace.com >>